InPractice Survey on the Treatment of Hypercholesterolemia

AstraZeneca2,500 enrolled

Overview

This is a multi-centre survey of patients who are currently on lipid-lowering pharmacological treatment. Data collection for each patient will take place at one visit.

Study Type

OBSERVATIONAL

Enrollment

2,500

Conditions

Hypercholesterolemia

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subject must be 18 years of age or older of either sex. * Subject is on lipid-lowering drug treatment for at least 3 months, with no dose change for a minimum of 6 weeks. Exclusion Criteria: * Subjects who are unwilling or unable to provide informed consent.

Locations (1)

Research Site

Hanoi, Vietnam

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.